Dale Tempco suggests DF(x) as an updated approach to DFM, as it addresses a wider range of benefits and provides a structured approach to new product development.
Read now
We asked three supplier companies with cleaning and finishing capabilities and a focus on AM to speak on successful techniques they see in use, and challenges that OEM customers are asking them to solve.
Continue to article
Extremities replacement device revenue reached nearly $2.8 billion in 2018, making it an attractive area for product introductions. We're highlighting six shoulder and ankle FDA clearances granted since the beginning of the year.
Learn more
We've covered 20 OEM-related merger and acquisition announcements so far this year, and seven of them are related to the spine sector. Of those, three were announced in rapid succession this quarter. Here's our in-depth look.
Keep reading
FDA 510(k) clearance was received to market the TIGER SHARK C interbody device with BioBond and the BOOMERANG Anterior Cervical Plate, for use together or separately in cervical spinal fusion.
Click to read more
The partnership will support CrossRoads' portfolio and market presence expansion. HealthpointCapital has committed additional equity capital to fund organic growth and bolt-on acquisitions.
Read more
FDA Releases UDI Guidance | What Engineers Need to Know About the Mill | Randy Theken Shares Views on Additive Manufacturing | FDA Finalizes UHMWPE Guidance
Continue to the Newsletter